Stay updated on Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.
Latest updates to the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page
- Check7 days agoChange DetectedVersion 61 (2026-02-13) adds Contacts/Locations and Study Status to the record history. A prior entry from 2026-01-14 was removed.SummaryDifference0.2%
- Check14 days agoChange DetectedAn administrative update adds Revision: v3.4.2 and removes older notices (lapse-in-funding notice and v3.4.1 reference). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check21 days agoChange DetectedA government funding notice was added and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%
- Check28 days agoChange DetectedThe new version adds a Show glossary option and green/red highlights for additions and deletions, and updates the Revision label to v3.4.0; the previous v3.3.4 entry is removed.SummaryDifference0.5%
- Check35 days agoChange DetectedA new 'Study Status' entry was added on 2026-01-13 and an entry from 2026-01-12 was removed in the record history.SummaryDifference0.2%
- Check43 days agoChange DetectedOn 2026-01-12, Eligibility and Study Status were added to the record history. A deletion occurred on 2025-12-17.SummaryDifference0.3%
Stay in the know with updates to Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.